Pharmaceutical Business Review - EntreMed has revealed that an an independent Data Safety Monitoring Board has conducted a favorable review of safety data from its breast cancer drug. The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients
Page 1 || Page 2 || Page 3 || Page 4 || Page 5
Times Online - So says the leading figure in Australia’s mesothelioma programme, Professor Bruce Robinson of the Queen Elizabeth II Medical In litigation-crazy America, 200,000 claims have been filed against T&N, some based only on the fear of getting asbestos
Annie Jennings
PRWeb - Mesothelioma & Asbestos Disease Warning Sign Pleural effusions are a possible warning sign for mesothelioma and other diseases caused by asbestos exposure, according to a new article from the Law Firm of Lewis & Scholnick (mesothelioma litigation